Literature DB >> 15545182

Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.

Kjell Oberg1, Lone Astrup, Barbro Eriksson, Sture E Falkmer, Ursula G Falkmer, Jens Gustafsen, Caj Haglund, Ulrich Knigge, Morten H Vatn, Matti Välimäki.   

Abstract

The incidence of neuroendocrine tumours of the gastroenteropancreatic system seems to have increased during the past decade. New diagnostic and therapeutic procedures have aroused the interest of physicians, though most see very few cases of such diseases. A group of members of the Nordic Neuroendocrine Tumour Group decided to compile some guidelines to facilitate the diagnosis and treatment of patients with these tumours. Part I of these guidelines discusses the principles of histopathology, biochemical and radiological diagnosis as well as therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545182     DOI: 10.1080/02841860410018575

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  41 in total

1.  Insulin secretion and insulin-producing tumors.

Authors:  Jean-Marc Guettier; Phillip Gorden
Journal:  Expert Rev Endocrinol Metab       Date:  2010-03-01

2.  The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.

Authors:  Meredith Cummins; Nick Pavlakis
Journal:  Ther Adv Med Oncol       Date:  2013-09       Impact factor: 8.168

3.  TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; A Couvelard; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

4.  Neuroendocrine tumour cells in the wall of a splenic artery aneurysm.

Authors:  Anders E Henriksson; Emanuela Vancea; Peter Pitkänen; Erik Wilander; David Bergqvist
Journal:  J Clin Pathol       Date:  2007-07       Impact factor: 3.411

Review 5.  Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.

Authors:  Guida M Portela-Gomes; Lars Grimelius; Mats Stridsberg
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

Review 6.  Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.

Authors:  Kai Yang; Ying-Sheng Cheng; Ji-Jin Yang; Xu Jiang; Ji-Xiang Guo
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

Review 7.  Medical treatment of gastrinomas.

Authors:  Christoph J Auernhammer; Burkhard Göke
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

8.  Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.

Authors:  Tetsuhide Ito; Hironobu Sasano; Masao Tanaka; R Yoshiyuki Osamura; Iwao Sasaki; Wataru Kimura; Koji Takano; Takao Obara; Miyuki Ishibashi; Kazuwa Nakao; Ryuichiro Doi; Akira Shimatsu; Toshirou Nishida; Izumi Komoto; Yukio Hirata; Kazuhiko Nakamura; Hisato Igarashi; Robert T Jensen; Bertram Wiedenmann; Masayuki Imamura
Journal:  J Gastroenterol       Date:  2010-02       Impact factor: 7.527

Review 9.  Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learned.

Authors:  James C Yao; Diane Reidy Lagunes; Matthew H Kulke
Journal:  Oncologist       Date:  2013-04-24

Review 10.  Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.

Authors:  Omar Abdel-Rahman; Mona Fouad
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-03       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.